DK0652767T3 - Behandling af manglende mælkedannelse hos mennesker - Google Patents
Behandling af manglende mælkedannelse hos menneskerInfo
- Publication number
- DK0652767T3 DK0652767T3 DK91916584T DK91916584T DK0652767T3 DK 0652767 T3 DK0652767 T3 DK 0652767T3 DK 91916584 T DK91916584 T DK 91916584T DK 91916584 T DK91916584 T DK 91916584T DK 0652767 T3 DK0652767 T3 DK 0652767T3
- Authority
- DK
- Denmark
- Prior art keywords
- treatment
- higf
- humans
- lack
- relates
- Prior art date
Links
- 230000015572 biosynthetic process Effects 0.000 title 1
- 239000008267 milk Substances 0.000 title 1
- 210000004080 milk Anatomy 0.000 title 1
- 235000013336 milk Nutrition 0.000 title 1
- 230000006651 lactation Effects 0.000 abstract 3
- 239000000203 mixture Substances 0.000 abstract 3
- 239000003623 enhancer Substances 0.000 abstract 2
- 230000000009 lactational effect Effects 0.000 abstract 2
- 238000004519 manufacturing process Methods 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 102000002265 Human Growth Hormone Human genes 0.000 abstract 1
- 108010000521 Human Growth Hormone Proteins 0.000 abstract 1
- 239000000854 Human Growth Hormone Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH], i.e. somatotropin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/25—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/30—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Diabetes (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Reproductive Health (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Processing Of Solid Wastes (AREA)
- Treatment Of Sludge (AREA)
- Separation Of Suspended Particles By Flocculating Agents (AREA)
- Compounds Of Unknown Constitution (AREA)
- Dairy Products (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NZ23476690 | 1990-08-03 | ||
PCT/SE1991/000503 WO1992002245A1 (en) | 1990-08-03 | 1991-07-19 | Treatment of human lactation failure |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0652767T3 true DK0652767T3 (da) | 2000-04-03 |
Family
ID=19923318
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK91916584T DK0652767T3 (da) | 1990-08-03 | 1991-07-19 | Behandling af manglende mælkedannelse hos mennesker |
Country Status (13)
Country | Link |
---|---|
US (1) | US5276014A (de) |
EP (1) | EP0652767B1 (de) |
JP (1) | JP3074302B2 (de) |
AT (1) | ATE184489T1 (de) |
AU (1) | AU643073B2 (de) |
CA (1) | CA2086754C (de) |
DE (1) | DE69131629T2 (de) |
DK (1) | DK0652767T3 (de) |
ES (1) | ES2138960T3 (de) |
GR (1) | GR3032156T3 (de) |
IE (1) | IE912345A1 (de) |
PT (1) | PT98563B (de) |
WO (1) | WO1992002245A1 (de) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ243071A (en) * | 1992-06-08 | 1994-09-27 | Kabi Pharmacia Ab | Igf-2 (or analogue) compositions for pharmaceutical uses |
EP0739204A4 (de) * | 1993-11-09 | 2000-03-15 | Merck & Co Inc | Piperidine, pyrrolidine und hexahydro-1h-azepine unterstützen die freisetzung des wachstumshormon |
EP0776213A1 (de) * | 1994-09-21 | 1997-06-04 | Pharmacia & Upjohn Aktiebolag | Verfahren für die behandlung von hypertonie in trächtigen säugetieren |
US5858966A (en) * | 1994-12-21 | 1999-01-12 | Auckland Uniservices Limited | Fetal growth |
GR1007178B (el) * | 1995-02-22 | 2011-01-31 | Πετρομανωλακης Εμμ. | Πρωραιος αγωγος σκαφους με διατομην αεροτομης. |
US5622932A (en) * | 1995-05-05 | 1997-04-22 | Eli Lilly And Company | IGF-1 superagonists |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3853833A (en) * | 1971-04-27 | 1974-12-10 | Hormone Res Foundation | Synthetic human growth-promoting and lactogenic hormones and method of producing same |
BG49718A3 (en) * | 1983-07-15 | 1992-01-15 | Bio Technology General Corp | Method for preparing of polypeptid with superoxiddismutasne activitty |
EP0193917A3 (de) * | 1985-03-06 | 1987-09-23 | American Cyanamid Company | Wasserdispersible und wasserlösliche Polymerzusammensetzungen für parenterale Anwendung |
AU6104686A (en) * | 1985-08-12 | 1987-02-19 | Syntex (U.S.A.) Inc. | Bovine growth hormone releasing factor perivative |
US4783524A (en) * | 1985-09-17 | 1988-11-08 | Monsanto Company | Growth factors |
CA1299103C (en) * | 1986-03-07 | 1992-04-21 | Robert Joseph Collier | Method and compositions for increasing mammary parenchyma |
IL86102A (en) * | 1987-05-11 | 1994-04-12 | Univ Tulane | Alkylated peptides that release growth hormone and their use |
FR2622455B1 (fr) * | 1987-11-04 | 1991-07-12 | Agronomique Inst Nat Rech | Application du facteur de stimulation de la secretion de l'hormone de croissance humaine, de ses fragments actifs et des analogues correspondants, pour augmenter la production laitiere et le poids des nouveau-nes chez les mammiferes |
US5089473A (en) * | 1988-08-29 | 1992-02-18 | Monsanto Company | Somatotropin variants and their use |
-
1991
- 1991-07-04 IE IE234591A patent/IE912345A1/en not_active IP Right Cessation
- 1991-07-19 AT AT91916584T patent/ATE184489T1/de not_active IP Right Cessation
- 1991-07-19 EP EP91916584A patent/EP0652767B1/de not_active Expired - Lifetime
- 1991-07-19 DK DK91916584T patent/DK0652767T3/da active
- 1991-07-19 ES ES91916584T patent/ES2138960T3/es not_active Expired - Lifetime
- 1991-07-19 JP JP03515025A patent/JP3074302B2/ja not_active Expired - Fee Related
- 1991-07-19 AU AU85108/91A patent/AU643073B2/en not_active Ceased
- 1991-07-19 WO PCT/SE1991/000503 patent/WO1992002245A1/en active IP Right Grant
- 1991-07-19 CA CA002086754A patent/CA2086754C/en not_active Expired - Fee Related
- 1991-07-19 DE DE69131629T patent/DE69131629T2/de not_active Expired - Fee Related
- 1991-08-02 PT PT98563A patent/PT98563B/pt not_active IP Right Cessation
- 1991-09-26 US US07/765,171 patent/US5276014A/en not_active Expired - Fee Related
-
1999
- 1999-12-15 GR GR990403242T patent/GR3032156T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
PT98563B (pt) | 1999-01-29 |
ES2138960T3 (es) | 2000-02-01 |
DE69131629D1 (de) | 1999-10-21 |
CA2086754C (en) | 2000-08-29 |
AU643073B2 (en) | 1993-11-04 |
EP0652767B1 (de) | 1999-09-15 |
EP0652767A1 (de) | 1995-05-17 |
JP3074302B2 (ja) | 2000-08-07 |
JPH05509329A (ja) | 1993-12-22 |
ATE184489T1 (de) | 1999-10-15 |
WO1992002245A1 (en) | 1992-02-20 |
IE912345A1 (en) | 1992-02-12 |
GR3032156T3 (en) | 2000-04-27 |
DE69131629T2 (de) | 2000-03-09 |
PT98563A (pt) | 1992-06-30 |
US5276014A (en) | 1994-01-04 |
CA2086754A1 (en) | 1992-02-04 |
AU8510891A (en) | 1992-03-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1201241A3 (de) | Zusammensetzungen enthaltend Capsaicin oder seine Analogen und Lokalanästhetika | |
ATE204178T1 (de) | Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin | |
BG103521A (en) | Substituted pyrimidinon and pyridon compounds and methods for their application | |
UA56989C2 (uk) | ФІЗІОЛОГІЧНО АКТИВНИЙ ПЕГ-КОН'ЮГАТ <font face="Symbol">a</font>-ІНТЕРФЕРОНУ, СПОСІБ ЙОГО ОДЕРЖАННЯ, ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ НА ЙОГО ОСНОВІ ТА СПОСІБ ЛІКУВАННЯ АБО ПРОФІЛАКТИКИ ІМУНОМОДУЛЯТОРНИХ ЗАХВОРЮВАНЬ | |
ATE112684T1 (de) | Verwendung von igf-ii zur behandlung von knochenkrankheiten. | |
ATE81781T1 (de) | Wachstumhormonzubereitungen mit verzoegerter wirkstoffabgabe fuer eine parenterale verabreichung und ihre verwendung. | |
BR8603315A (pt) | Processo para produzir um implante de liberacao controlada;implante usado no processo;processo para purificar e concentrar hormonio de crescimento biologicamente ativo em uma forma adequada para incorporacao em um implante para administracao subcutanea | |
AU2147992A (en) | Immunogen compounds having specifically an anti-cytokine effect, method of preparation, pharmaceutical compositions and kits containing them | |
SE8802569D0 (sv) | Improvements in or relation to somatostatins | |
ES2102393T3 (es) | Complejos de acido quinolona carboxilico--ion metalico--acido. | |
ATE55695T1 (de) | Verwendung von defibrotid zur herstellung pharmazeutischer zusammensetzungen zur behandlung peripherer arteriopathien. | |
DK0652767T3 (da) | Behandling af manglende mælkedannelse hos mennesker | |
MX9701187A (es) | Nuevas lactamas naftofusionadas n-substituidas. | |
EG19302A (en) | Compound with gastric acid inhibitory effect and process for its preparation | |
ATE59295T1 (de) | Prazosin-pirbuterol-mischung zur bronchendilatation. | |
HUP9903679A2 (hu) | Olanzapin alkalmazása bipoláris zavar kezelésére szolgáló gyógyszerkészítmények előállítására | |
DE69734349D1 (de) | Behandlung von knochenleiden mit adrenomedullin | |
IE840977L (en) | Pharmaceutical preparations | |
GB1507643A (en) | 4-(5-nitro-2-furyl)quinaldinic acid n-oxide and its use in the treatment of bovine mastitis | |
DK15088A (da) | Antibakterielt lyofiliseret praeparat | |
DE68928488T2 (de) | Zusammensetzungen und verabreichungsverfahren für heilmittel | |
DE59002790D1 (de) | Verfahren zur Herstellung einer Galenischen Zubereitung mit optimaler Bioverfügbarkeit des Wirkstoffs 2-Hydroxy-5-methyllaurophenonoxime (HMLO). | |
DE60217302D1 (de) | Erhaltung von körpereigenen proteinen |